1. WASF3 Knockdown Sensitizes Gastric Cancer Cells to Oxaliplatin by Inhibiting ATG12-Mediated Autophagy
   Yanli Nie et al, 2020, The American Journal of the Medical Sciences CrossRef
2. EphA2 affects the sensitivity of oxaliplatin by inducing EMT in oxaliplatin-resistant gastric cancer cells
   Qiaocheng Wen et al, 2017, Oncotarget CrossRef
3. Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab
   Huanrong Ma et al, 2018, International Journal of Cancer CrossRef
4. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer
   Xing‐Chun Peng et al, 2018, Cancer Medicine CrossRef
5. DLC1 inhibits lung adenocarcinoma cell proliferation, migration and invasion via regulating MAPK signaling pathway
   Niu Niu et al, 2021, Experimental Lung Research CrossRef
6. Identification and validation of prognostic autophagy-related genes associated with immune microenvironment in human gastric cancer
   Ruyue Tian et al, 2022, Aging CrossRef
7. DLC1 as Druggable Target for Specific Subsets of Gastric Cancer: An RNA-seq-Based Study
   Lianlei Yang et al, 2023, Medicina CrossRef
8. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer
   Zhenhua Huang et al, 2018, BMC Cancer CrossRef
9. Tumor suppressor gene DLC1: Its modifications, interactive molecules, and potential prospects for clinical cancer application
   Guanghui Ren et al, 2021, International Journal of Biological Macromolecules CrossRef
10. MiR-200a-3p promotes gastric cancer progression by targeting DLC-1
    Zhipeng Li et al, 2022, Journal of Molecular Histology CrossRef
11. Deleted in liver cancer 1 suppresses the growth of prostate cancer cells through inhibiting Rho-associated protein kinase pathway
    Hua Gong et al, 2023, Asian Journal of Urology CrossRef
12. Functional antagonism between CagA and DLC1 in gastric cancer
    Isabel Hinsenkamp et al, 2022, Cell Death Discovery CrossRef